India has 1 in 10 adults with thyroid disease. Most managed on TSH alone. That's not enough.
15–20% of hypothyroid patients don't respond to T4 alone — because their Free T3 (the active hormone) remains low despite a normal TSH. Hashimoto's thyroiditis — the most common cause of hypothyroidism — cannot be detected without Anti-TPO antibody testing. Graves' disease requires TRAb. At Gini, Dr. Anil Bhansali orders the full thyroid panel for every patient — because what TSH alone misses changes the diagnosis and the treatment.
📍 Sector 69, Mohali · 15 min from Chandigarh · 20 min from Panchkula · Free Parking
India has approximately 42 million people with thyroid disease — making it the most common endocrine disorder after diabetes. Yet the vast majority are managed on a single annual TSH test and a standard levothyroxine dose. For many patients, this is adequate. But for 15–20% of hypothyroid patients, a normal TSH on T4 replacement does not mean they feel well — because Free T3 (the active hormone that functions at the cellular level) remains suboptimal.
Dr. Bhansali orders the full thyroid panel for every new thyroid patient — TSH + Free T3 + Free T4 + Anti-TPO + Anti-TG, with TRAb added when hyperthyroidism is suspected, and thyroid ultrasound correlation for nodule evaluation. The panel adds minimal cost but provides the complete clinical picture that allows correct diagnosis and optimised treatment on the first consultation.
Each marker serves a distinct clinical purpose. Together they provide a complete thyroid picture.
Underactive thyroid causing fatigue, weight gain, cold intolerance, brain fog, constipation, hair loss, and dry skin. Treated with levothyroxine (T4), and in refractory cases with combination T4+T3 therapy based on Free T3 levels. Dose optimised by full panel — not just TSH target.
Overactive thyroid causing weight loss, palpitations, tremor, anxiety, heat intolerance, and eye changes (in Graves'). Treatment options: antithyroid drugs (Carbimazole, PTU), radioactive iodine therapy, or surgery — decision based on TRAb levels, gland size, and patient profile.
Autoimmune hypothyroidism — the most common thyroid condition. Identified by elevated Anti-TPO +/- Anti-TG antibodies. Management includes appropriate levothyroxine dosing, monitoring for antibody progression, dietary guidance (iodine excess avoidance, gluten consideration), and screening for associated autoimmune conditions.
TSH elevated but Free T4 still normal — a transitional state that may or may not require treatment. Decision to treat depends on TSH level, Anti-TPO positivity (autoimmune = higher progression risk), symptoms, age, pregnancy status, and cardiovascular risk. Not all subclinical cases need medication.
Autoimmune hyperthyroidism confirmed by elevated TRAb. May be associated with Graves' ophthalmopathy (eye changes). Treatment selection (antithyroid drugs vs radioactive iodine vs thyroidectomy) guided by antibody titre, gland size, eye disease presence, and patient preference. Long-term remission monitoring.
Thyroid nodules are common (found in 60–70% of the population by ultrasound). Most are benign. Risk stratification uses ultrasound TIRADS scoring — size, echogenicity, calcification, vascularity. Only high-risk nodules need fine needle aspiration cytology (FNAC). Dr. Bhansali determines which nodules need biopsy and which need monitoring.
Thyroid requirements increase by 30–50% during pregnancy. Uncontrolled hypothyroidism in pregnancy is associated with miscarriage, pre-eclampsia, and impaired fetal neurological development. TSH targets in pregnancy are tighter (0.1–2.5 in first trimester). Anti-TPO positive women need dose increase from the day of confirmed pregnancy.
15–20% of hypothyroid patients on levothyroxine continue to experience symptoms — fatigue, weight gain, brain fog, depression — despite a "normal" TSH. In these patients, Free T3 is often low. Dr. Bhansali evaluates for combination T4+T3 therapy (levothyroxine + liothyronine), which restores Free T3 to normal and resolves persistent symptoms in many patients.
Gini Hospital is in Sector 69 Mohali. Patients travel from Chandigarh (15 min), Panchkula (20 min), Zirakpur (8 min), Kharar (15 min), Amritsar, Jalandhar, Ludhiana, Shimla, Ambala, and across Punjab, Haryana, and Himachal Pradesh to see Dr. Bhansali for thyroid conditions.
Online video consultations available for initial assessments and follow-ups.
Full thyroid panel — not just TSH. The most experienced thyroid specialist in North India. 15 minutes from Chandigarh. Mon–Sat, 10 AM–6 PM.